Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
First-in-human crossover PK/PD study of MYL-1401H versus EU and US Neulasta in healthy volunteers
NL-OMON40799Active, not recruiting
- Sponsor
- Mylan
- Start
- Aug 2014
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Randomised, double-blind trial of pegfilgrastim in neutropenia (3 arms), sponsored by Mylan. Primary endpoint: Pharmacokinetics/Pharmacodynamics and safety. Started Aug 2014; status: active, not recruiting.
02
Drugs
pegfilgrastim
03
Conditions
neutropenia
Beyond the preview
Go deeper on NL-OMON40799.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON40799.